OutSee

Genomics and drug discovery company leveraging artificial intelligence for target identification.

Cambridge, UK—Website

£4.3MTotal raised

OutSee is a genomics and drug discovery company that uses predictive AI to identify therapeutic targets. The firm applies its Nomaly platform to precision medicine and target discovery.

Founders

Julian Gough

CEO and Founder

Investors

Seed12 January 2026
£2.5M
Ahren Innovation CapitalLeadFollow-on
Kadmos CapitalFollow-on
P
Panacea
Empirical VenturesFollow-on
Seed24 June 2025
£1.8M
Ahren Innovation CapitalLead
Kadmos Capital
Empirical Ventures
PV
Panacea Ventures

Funding history

Seed12 January 2026

£2.5M

OutSee raises £2.5m in a seed round led by Ahren Innovation Capital to advance its genomics platform.

The oversubscribed financing was led by Ahren Innovation Capital and will support preclinical validation and platform development.

Seed24 June 2025

£1.8M

OutSee secures £1.8m in seed funding led by Ahren Innovation Capital to expand target discovery operations.

The financing round was led by Ahren Innovation Capital and will support the expansion of the company's in-house target discovery programme.